Vertex Pharmaceuticals, Inc’s filing revealed that its Director LR 2019 Benefit Trust acquired Company’s shares for reported $76021.0 on May
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Vertex Pharmaceuticals, Inc’s recent filing unveils that its Director LR 2019 Benefit Trust acquired Company’s shares for reported $76021.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vertex Pharmaceuticals,
Vertex Pharmaceuticals, Inc’s recently made public that its Officer ALTSHULER DAVID acquired Company’s shares for reported $22084.0 on May 15